U.S. Lipid Regulators Markets

 

Regular Price: USD 3,950

Special Price USD 2,765

30% OFF

* Required Fields

Regular Price: USD 3,950

Special Price USD 2,765

PAY BY INVOICE

Be the first to review this product

This report analyzes the U.S. lipid regulators markets, for the forecast period 1998 to 2008. The report is segmented into 4 chapters viz. Executive Summary, Total Market, Statins Market and Non-Statin Market. Each segment provides revenue forecasts, market share, pricing trends, demand analysis, competitive structure and market and technology trends. Drivers, restraints and challenges and the strategic recommendations are also discussed. The Market Engineering Awards are conferred on deserving companies.

Table of Contents

U.S. Lipid Regulators Markets, Executive SummaryExecutive SummaryExecutive SummaryU.S. Lipid Regulators Markets, Total MarketOverviewIntroductionNCEP GuidelinesMarket Engineering AnalysisForecasts and TrendsDemand AnalysisRevenue ForecastsPricing AnalysisTechnology TrendsChallenges and StrategiesStrategies OverviewLow Awareness Limits Drug Utilization to High-Risk PatientsNon-Adherence to NCEP Guidelines by Physicians Truncates GrowthPoor Compliance Decimates Growth PotentialIntroduction of Low Cost Generics to Constrain Market ExpansionIntroduction of Combination Drugs Threatens Sustenance of Growth TrendsMarket Engineering AwardsMarketing Strategy Leadership Award - PfizerBusiness Development Strategy Award - Merck and Co.Competitive Strategy Award - Bristol-Myers SquibbProduct Launch Strategy Award - KOS PharmaceuticalsTechnology Innovation Award - Avant ImmunotherapeuticsU.S. Lipid Regulators Markets, Statins MarketBranded Statins Market OverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsDemand AnalysisRevenue ForecastsPricing AnalysisCompetitive StructureProduct AnalysisMarket Share AnalysisStatin Combinations Market OverviewIntroductionMarket Engineering AnalysisMarket DriversMarket RestraintsDemand AnalysisRevenue ForecastsProduct AnalysisGeneric Statin Market OverviewImpact of GenericsDemand AnalysisRevenue ForecastsU.S. Lipid Regulators Markets, Non-Statins MarketFibric-Acid Derivatives MarketOverviewMarket Engineering AnalysisDemand AnalysisRevenue ForecastsProduct AnalysisBile-Acid Sequestrants MarketOverviewMarket Engineering AnalysisRevenue ForecastsNicotinic Acid Derivatives MarketOverviewMarket Engineering AnalysisRevenue ForecastsNew Products MarketOverviewRevenue ForecastsProduct AnalysisU.S. Lipid Regulators Markets, Decision Support DatabaseCausal FactorsIncidence of Myocardial InfarctionMortality due to Myocardial InfarctionMortality due to Coronary Heart DiseasePrevalence percent of Cardiovascular DiseasesPrevalence of Obese PopulationDiabetes PrevalencePrevalence of HypertensionDemographicsMale Population over 65 Years of AgeFemale Population over 65 Years of AgeTotal Population over 65 Years of Age




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 13-Dec-17

Region : North America

Release Date : 13-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Release Date : 12-Dec-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.